Infinium Pharmachem Ltd vs Onyx Biotec Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Infinium Pharmachem Ltd is ₹ 219.9 as of 04 May 09:29 . The P/E Ratio of Infinium Pharmachem Ltd changed from 28.2 on March 2024 to 46.3 on March 2025 . This represents a CAGR of 28.13% over 2 yearsThe P/E Ratio of Onyx Biotec Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Infinium Pharmachem Ltd changed from ₹ 318.68 crore on March 2024 to ₹ 376.96 crore on March 2025 . This represents a CAGR of 8.76% over 2 yearsThe Market Cap of Onyx Biotec Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The Dividend Payout of Infinium Pharmachem Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Onyx Biotec Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Infinium Pharmachem Ltd

Infinium Pharmachem Limited was originally incorporated as 'Infinium Pharmachem Private Limited' on November 21, 2003 issued by the Registrar of Companies, Gujarat.
Later on, Company converted its status into Public Company and the name of Company was changed to 'Infinium Pharmachem Limited' vide fresh Certificate of Incorporation dated August 12, 2022.
Company is engaged in manufacturing and selling of Iodian based Pharmaceutical Intermediates.
The Company has its manufacturing plant at Dist.
Anand, Gujarat, since inception. The Company's manufacturing capabilities and technical expertise have catered industries such as Pharmaceutical & Biotech, Specialty & Performance Chemicals, Agrochemicals, Human Health, Animal Health, Cosmetics, Sanitation, Electrical, Electronics, etc.

About Onyx Biotec Ltd

Onyx Biotec Limited was incorporated as Onyx Biotec Private Limited', pursuant to a Certificate of Incorporation dated May 13, 2005 issued by the Registrar of Companies, Punjab, H.P. & Chandigarh.
Further, Company converted into a Public Limited and the name was changed to Onyx Biotec Limited' and a fresh Certificate of Incorporation dated July 23, 2024 was issued by the Registrar of Companies, Central Processing Centre. Onyx started its operation in pharmaceutical industry with sterile water for injections with capacity of 2 lacs units per day in year 2010.
Since then, Onyx is engaged in Manufacturing of Pharmaceutical Products such as sterile water ampoule, dry injection, dry syrup etc. to major corporations, which includes the top pharma companies. Presently, the Company manufactures Sterile Water for Injections, and acts as a pharmaceutical contract manufacturer offering a comprehensive range of Dry Powder Injections and Dry Syrup for India and overseas.

FAQs for the comparison of Infinium Pharmachem Ltd and Onyx Biotec Ltd

Which company has a larger market capitalization, Infinium Pharmachem Ltd or Onyx Biotec Ltd?

Market cap of Infinium Pharmachem Ltd is 336 Cr while Market cap of Onyx Biotec Ltd is 59 Cr

What are the key factors driving the stock performance of Infinium Pharmachem Ltd and Onyx Biotec Ltd?

The stock performance of Infinium Pharmachem Ltd and Onyx Biotec Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Infinium Pharmachem Ltd and Onyx Biotec Ltd?

As of May 4, 2026, the Infinium Pharmachem Ltd stock price is INR ₹216.25. On the other hand, Onyx Biotec Ltd stock price is INR ₹33.0.

How do dividend payouts of Infinium Pharmachem Ltd and Onyx Biotec Ltd compare?

To compare the dividend payouts of Infinium Pharmachem Ltd and Onyx Biotec Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.